Former Stanford president, Marc Tessier-Lavigne, is the CEO of new biopharma startup, Xaira. The startup already has $1 billion in investments and seeks to use AI to generate molecules to treat diseases. Read this story
Former Stanford president, Marc Tessier-Lavigne, is the CEO of new biopharma startup, Xaira. The startup already has $1 billion in investments and seeks to use AI to generate molecules to treat diseases. Read this story
More from Stanford Daily | biopharma drug development marc tesser-lavigne mtl research stanford startup Science & Technology News Marc Tesser-Lavigne MTL Stanford